PAR paradigm biopharmaceuticals limited..

Ann: Consistent pain reduction and improvement in function data, page-2

  1. 4,905 Posts.
    lightbulb Created with Sketch. 7633
    https://hotcopper.com.au/data/attachments/2866/2866686-01fafe8d4079a5ec1cb0f9b821085eea.jpg


    I've added the emphasis...key points for me

    1) Great additional data, adds to the set nicely.
    2) CONSISTENCY, very important
    3) Safety first - No AE's reported in last batch
    4) Affirmation Q3 SAS Revenue (maybe modest, but still revenue) is possible in this area.
    Last edited by Mozzarc: 03/02/21
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
40.3¢
Change
-0.018(4.17%)
Mkt cap ! $160.9M
Open High Low Value Volume
41.5¢ 41.5¢ 40.0¢ $103.5K 254.8K

Buyers (Bids)

No. Vol. Price($)
1 277 41.5¢
 

Sellers (Offers)

Price($) Vol. No.
39.0¢ 42 1
View Market Depth
Last trade - 15.59pm 21/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.